期刊文献+

胃癌组织胸苷酸合成酶与5-Fu药敏关系 被引量:2

The Correlation between the Level of TS and Sensitivity of Gastric Cancer Tissue to 5-Fluorouracil in Vitro
下载PDF
导出
摘要 目的探讨胃癌组织胸苷酸合成酶(TS)表达水平与5-氟尿嘧啶(5-Fu)耐药性的关系。方法用ATP-TCA法对35例胃癌患者新鲜标本进行5-Fu体外药敏检测;免疫组化法检测其TS表达水平,比较分析不同TS表达水平与体外药敏有效率的关系。结果TS高表达组有效率18.8%(3/16);TS低表达组有效率52.9%(9/17)。TS高、低表达组对5-Fu敏感性差异有统计学意义(P<0.05)。结论胃癌组织TS表达水平与5-Fu敏感性可能有关,TS的表达水平检测可能有助于预测胃癌组织对5-Fu的敏感性。 Objective To investigate correlation between the level of thymidylate synthase and the antitumor activities of 5-fluorouracil (5-Fu) determined by ATP sensitivity test in vitro. Methods The gastric carcinoma cells taken from fresh samples of 35 patients with the cancer were cultured in vitro to test the sensitivity of these cells to 5-Fu with the method of ATP-TCA. The level of TS was detected by means of immunohistochemistry,and the correlation between the level of TS and chemosensitivity assay was then analyzed. Results The response rate of the highlevel TS group to 5-Fu was 18.8%(3/16) and was significantly lower than that of the low-level TS group(52.90%,9/17,P〈0.05).Conclusion The results in the present study suggest that the level of TS is associated with the antitumor activities of 5-fluorouracil, indicating that the level of TS might be used as stratification maker for predicting the antitumor activities of 5-fluorouracil.
出处 《实用临床医学(江西)》 CAS 2008年第6期21-23,共3页 Practical Clinical Medicine
基金 江西省卫生厅科技计划项目(20071119)
关键词 胃癌 胸苷酸合成酶 5-氟尿嘧啶 体外药敏实验 gastric cancer thymidylate synthase 5-fluorouracil chemosensitivity assay in vitro
  • 相关文献

参考文献4

  • 1Kurbacher C M,Cree I A,Bruckner H W,et al. Use of an Ex Vivo ATP luminescence Assay to Direct Chemotherapy for Recurrent Ovarian Cancer[J]. Anticancer Drugs, 1998 , 9 (1) : 51- 57.
  • 2Gonen M, Hummer A, Zervoudakis A, et al. Thymidylate Synthase Expression in Hepatic Tumors is a Predictor of Survival and Progression in Patients with Resectable Metastatic Colorectal Cancer[J].J Clin Oncol,2003,21(3):406-412.
  • 3田海梅,李艳芬,吴健雄,曹冬艳,荣维淇,刘毅,李茉,王海鹏,王小兵,张伟.应用ATP生物荧光肿瘤体外药敏检测技术研究大肠癌药敏的异质性[J].癌症进展,2005,3(5):436-441. 被引量:6
  • 4Copur S,Aiba K,Drake J C,et al. Thymidylate Synthase Gene Amplification in Human Colon Cancer Cell Lines Resistant to 5-fluorouracil[J]. Biochem Pharmacol, 1995, 49 ( 10 ) : 1419- 1426.

二级参考文献4

共引文献5

同被引文献27

  • 1周志伟,王国强,万德森,潘志忠,李苏,陈功,廖海.二氢嘧啶脱氢酶活性与结直肠癌患者5-FU辅助化疗毒性关系的研究[J].癌症,2004,23(z1):1512-1516. 被引量:6
  • 2彭柔君,董秋美,史艳侠,曹烨,周中梅,袁中玉,李苏,廖海,姜文奇.胃癌患者外周血DPD活性、5-FU血药浓度与毒性反应的相关性分析[J].癌症,2006,25(8):1039-1043. 被引量:8
  • 3徐皖湘,陈振东.二氢嘧啶脱氢酶活性在食管癌5-FU化疗中的应用价值[J].安徽医科大学学报,2007,42(1):84-86. 被引量:3
  • 4马韬,叶正宝,刘炳亚,燕敏,张俊,朱正纲,尹浩然.胸苷酸合成酶、二氢嘧啶脱氢酶和胸苷磷酸化酶mRNA在胃癌中的表达及其意义[J].中华实验外科杂志,2007,24(5):534-536. 被引量:6
  • 5Hur H, Kang J, Kim NK, et al. Thymidylate synthase gene poly-morphism affects the response to preoperative 5 -fluorouracil chemo-radiationtherapy in patients with rectal cancer. Int J Radiat OncolBiol Phys, 2011,81(3) :669-676.
  • 6van Kuilenburg AB. Dihydropyrimidine dehydrogenase and the effi-cacy and toxicity of 5-fluorouracil. Eur J Cancer, 2004,40 ( 7 ):939-950.
  • 7Gamelin E, Delva R, Jacob J, et al. Individual fluorouracil doseadjustment based on pharmacokinetic follow-up compared with con-ventionaldosage : results of a multicenter randomized trial of patientswith metastatic colorectal cancer. J Clin Oncol, 2008,26(13):2099-2105.
  • 8Kubota T. 5-fluorouracil and dihydropyrimidine dehydrogenase. IntJ Clin Oncol, 2003,8(3):127-131.
  • 9Gardiner SJ, Begg EJ, Robinson BA. The effect of dihydropyrimi-dine dehydrogenase deficiency on outcomes with fluorouracil. Ad-verse Drug React Toxicol Rev, 2002,21(1-2) :1-16.
  • 10Gamelin E,Boisdron-Celle M, Gu6rin-Meyer V, et al. Correlation be-tween uracil and dihydrouracil plasma ratio, fluorouracil (5-FU) phar-macokinetic parameters, andtolerance in patients with advanced color-ectal cancer : A potential interest for predicting 5-FU toxicity anddeter-raining optimal 5-FU dosage. J Clin Oncol, 1999,17(4) :1105.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部